Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. NB804434

Novus Biologicals™ Mcl-1 Recombinant Protein Antigen
SDP

Catalog No. NB804434 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB804434 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB804434 Supplier Novus Biologicals™ Supplier No. NBP252968PEP
Add to Cart
Add to Cart

Description

Recombinant Protein

Specifications

For Use With (Application) Antibody Competition
Formulation PBS and 1 M Urea, pH 7.4.
Gene ID (Entrez) 4170
Molecular Weight (g/mol) MolecularWeight-theroretical: 29 kDa
Quantity 0.1 mL
Storage Requirements Store at -20°C. Avoid freeze/thaw cycles.
Gene Alias bcl2-L-3, BCL2L3MGC104264, Bcl-2-like protein 3, Bcl-2-related protein EAT/mcl1, EAT, induced myeloid leukemia cell differentiation protein Mcl-1, Mcl-1, mcl1/EAT, MCL1-ES, MCL1L, MCL1S, MGC1839, myeloid cell leukemia ES, myeloid cell leukemia sequence 1 (BCL2-related), TM
Gene Symbol MCL1
Inhibitor Properties This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-52968. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/mL
Research Category Apoptosis, Cancer, Signal Transduction, Tumor Suppressors
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Protein Mcl-1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.